Wilmer Cutler Pickering Hale and Dorr has advised Hemab Therapeutics Holdings, Inc. Goodwin Procter has advised the underwriters. Hemab Therapeutics Holdings, Inc., a clinical-stage biotechnology company,...
Hemab Therapeutics Closes Upsized Initial Public Offering on Nasdaq
Hemab’s $135 Million Series B Financing Round
Mazanti-Andersen advised Hemab on the deal. The Denmark and US-based biotech company Hemab raised USD 135 million in oversubscribed series B financing. Access Biotechnology led the round...


























